Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Shugo Ueda"'
Autor:
Junya Kawasoe, Yoichiro Uchida, Hiroshi Kawamoto, Tomoyuki Miyauchi, Takeshi Watanabe, Kenichi Saga, Kosuke Tanaka, Shugo Ueda, Hiroaki Terajima, Kojiro Taura, Etsuro Hatano
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Liver ischemia and reperfusion injury (IRI) is one of the obstacles in liver surgery such as liver resection and transplantation. In this study, we investigated the preventive effect on mouse liver IRI by feeding mice with inulin, which is a heteroge
Externí odkaz:
https://doaj.org/article/c3f94e03f44345f1b0dcce5213d4cd37
Autor:
Mikiya Ishihara, Shinichi Kageyama, Yoshihiro Miyahara, Takeshi Ishikawa, Shugo Ueda, Norihito Soga, Hiroaki Naota, Katsumi Mukai, Naozumi Harada, Hiroaki Ikeda, Hiroshi Shiku
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Cancer testis (CT) antigens are promising targets for cancer immunotherapies such as cancer vaccines and genetically modified adoptive T cell therapy. In this study, we evaluated the expression of three CT antigens, melanoma-assoc
Externí odkaz:
https://doaj.org/article/20436dffba2045e08c3308ed02b352e7
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Adoptive transfer of MAGE-A4 T-cell receptor gene−transduced lymphocytes in patients with recurrent esophageal cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a05db4f3837a87f220f5fd30fb26204
https://doi.org/10.1158/1078-0432.22457964
https://doi.org/10.1158/1078-0432.22457964
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Disease progression and overall survival of 10 patients who received transfer of TCR-transduced lymphocytes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f31f40d6bea1982d6bef623527fd30a
https://doi.org/10.1158/1078-0432.22457943.v1
https://doi.org/10.1158/1078-0432.22457943.v1
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Purpose: Preparative lymphodepletion, the temporal ablation of the immune system, has been reported to promote persistence of transferred cells along with increased rates of tumor regression in patients treated with adoptive T-cell therapy. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435287d64f78540ed161bfddcd2e6aff
https://doi.org/10.1158/1078-0432.c.6523764.v1
https://doi.org/10.1158/1078-0432.c.6523764.v1
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Peptides which have homologue sequences with MAGE-A4143-151 peptide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440d376ad6a083a3536ef12bbf844d64
https://doi.org/10.1158/1078-0432.22457937
https://doi.org/10.1158/1078-0432.22457937
Autor:
Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, Satoshi Kokura, Tetsuya Okayama, Tetsuya Abe, Masahiko Murakami, Koji Otsuka, Tomotake Ariyoshi, Takashi Kojima, Ken Taniguchi, Shinichiro Kobayashi, Hideaki Shimada, Satoshi Yajima, Takashi Suzuki, Satoshi Hirano, Takahiro Tsuchikawa, Toshiaki Shichinohe, Shugo Ueda, Kengo Kanetaka, Akira Yoneda, Hisashi Wada, Yuichiro Doki, Hiroki Yamaue, Masahiro Katsuda, Masaki Ohi, Hiromi Yasuda, Ken Kondo, Masato Kataoka, Yasuhiro Kodera, Masahiko Koike, Taizo Shiraishi, Yoshihiro Miyahara, Naoki Goshima, Eriko Fukuda, Kei Yamaguchi, Eiichi Sato, Hiroaki Ikeda, Tomomi Yamada, Masaharu Osako, Kaoru Hirai, Hiroshi Miyamoto, Takashi Watanabe, Hiroshi Shiku
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2743-2755
The aim of this study was to determine the efficacy and the biomarkers of the CHP-NY-ESO-1 vaccine complexed with full-length NY-ESO-1 protein and a cholesteryl pullulan (CHP) in patients with esophageal squamous cell carcinoma (ESCC) after surgery.
Autor:
Takayuki Nobuoka, Koji Nakada, Hisashi Shimizu, Takuya Noguchi, Masahide Kaji, Mikihiro Kano, Yoshikazu Uenosono, Shugo Ueda, Sang-Woong Lee, Atsushi Oshio
Publikováno v:
Surgery Today. 52:832-843
This retrospective nationwide survey investigated the quality of life (QOL) of patients with esophagogastric junction cancer after gastrectomy using the Postgastrectomy Syndrome Assessment Scale-45. The Postgastrectomy Syndrome Assessment Scale-45 co
Autor:
Jin Matsuyama, Sachiko Yamamoto, Takayuki Kii, Hiroki Hara, Ryohei Kawabata, Junji Kawada, Atsushi Takeno, Shugo Ueda, Hisato Kawakami, Yoshihiro Okita, Shunji Endo, Yutaka Kimura, Kazuhiro Yanagihara, Tatsuya Okuno, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh
Publikováno v:
Diseases of the Esophagus. 35
There is no standard chemotherapy for esophageal squamous cell carcinoma (ESCC) refractory to first-line fluoropyrimidine- and platinum-based chemotherapy. We therefore performed a randomized, selection-design phase II trial to compare docetaxel (DTX
Autor:
Yukinori Kurokawa, Junya Fujita, Tomono Kawase, Yutaka Kimura, Hiroshi Imamura, Hisato Kawakami, Masahiro Goto, Kazuhiro Nishikawa, Norimasa Fukushima, Shugo Ueda, Naotoshi Sugimoto, Jin Matsuyama, Taroh Satoh, Daisuke Sakai, Takao Tamura, Toshio Shimokawa
Publikováno v:
International Journal of Clinical Oncology. 26:1871-1880
To compare irinotecan-alone, paclitaxel-alone, and each combination chemotherapy with S-1 in patients with advanced gastric cancer (AGC) that is refractory to S-1 or S-1 plus cisplatin (SP). Patients with AGC after first-line chemotherapy with S-1 or